Logo for Gabather

Gabather Investor Relations Material

Latest events

Logo for Gabather

Q3 2024

28 Nov, 2024
Logo for Gabather

Q2 2024

29 Aug, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies

Latest reports from Gabather

Access all reports
Gabather AB is a pharmaceutical company dedicated to developing therapeutics for central nervous system diseases. The company focuses on creating novel drug candidates primarily for the treatment of neuropsychiatric disorders, including anti-psychotics, anti-depressants, anxiolytics, analgesics, and cognition-enhancing treatments. The company is headquartered in Stockholm, Sweden, and its shares are listed on the Stockholm Stock Exchange.